Opthea investors are fighting over a smaller pool of cash after the failed eye drug developer reported $80 million of June quarter outflows.

Phase 2 drilling by Ora Banda at the Davyhurst project expands the multi-lode gold system at Little Gem to a strike of more than 1km.

A desktop review and first-pass fieldwork identifies several iron-enriched rock chip samples at CuFe’s Camp Creek project in ...

With the Sydney Marathon looming, this tech editor turns to Samsung’s AI running coach. Can this smart watch salvage a ...

The ASX lifted 0.11pc in the first hour this morning, gaining on a rising oil price and resulting strength in the energy sector.

This episode of Who's Who looks at Ora Banda Mining (ASX:OBM), who is making moves in WA with surging gold output and big plans for FY26.

The RBA's monetary policy board “clearly remains nervous about inflation”, with a major bank warning a rate cut is not a lock in August.

Over a working life, a series of seemingly small choices can cost women up to $1m in lost earnings and wealth.

How an under-the-radar Aussie player is wiring up Asia’s smart cities, feeding AI with live data from half a million devices.

Everest Metals’ gold projects promise near-term cashflow while its Mt Edon rubidium project has the potential to be truly ...

Dimerix, Audeara, LTR Pharma and EZZ Life Science are among ASX health companies reporting quarterly results this week.

Island Pharmaceuticals hopes the US FDA will approve its acquired asset Galidesivir on the back of animal testing alone.